Contributors. In memoriam. List of Special Reviews. How to use this book. Essay: Databases, privacy, and confidentiality - effect of proposed new legislation on pharmacoepidemiology and drug safety monitoring (R.D. Mann). Central nervous system stimulants and drugs that suppress appetite (R.P. Sequeira). Antidepressant drugs (A.H. Young, P.J. Cowen). Lithium (M. Schou).
Drugs of abuse (E. Wong, J.K. Patel, A.I. Green). Hypnotics and sedatives (T.C. Jerram). Antipsychotic drugs (D. Capellà, A. Figueras). Anticonvulsant
drugs (E. Perucca). Opioid analgesics and narcotic antagonists (A.H. Ghodse, R.E. Edwards). Antipyretic analgesics (A. Iorio, G. Agnelli). Anti-inflammatory analgesics and drugs used in gout (A. Del Favero). General anesthetics and therapeutic gases (Y. Guédès, D. Carlhant). Local anesthetics (J.K. Aronson). Neuromuscular blocking agents and skeletal muscle relaxants (F.J. Richardson, S. Agoston). Drugs affecting autonomic functions or the extrapyramidal system (M. Schachter). Dermatologic drugs, topical drugs and cosmetics (A.C. de Groot). Antihistamines (L. Turner, V. Harris). Positive notropic drugs and drugs used in dysrhythmias (J.K. Aronson). bgr;-adrenoceptor antagonists and antianginal drugs (A.P. Maggioni, M.G. Franzosi, R. Latini). Drugs acting on the cerebral and peripheral circulation (R. Verhaeghe). antihypertensive drugs (F. Zannad). Diuretic drugs (G.T.McInnes). Metals (G.B. van der Voet, F.A. de Wolff). Metal antagonists (R.H.B. Meyboom, I.A. Jaffe). Antiseptic drugs and disinfectants (P. Magee). Penicillins, cephalosporins and other &bgr;-lactam antibiotics (T. Midtvedt). Miscellaneous antibacterial drugs (T. Midtvedt, D. Greenwood). Antifungal drugs (V.K. Lephakhin, A.V. Astakhova). Antiprotozoal drugs (M. Pirmohamed, P.A. Winstanley). Antiviral drugs (P. Reiss, M.D. de Jong). Drugs used in tuberculosis and leprosy (A. Noble, C.J. Ellis). Anthelminthics (A.G.C. Bauer). Enzymes and enzyme inhibitors (C.J. van Boxtel). Immunobiological preparations (S. Dittmann). Blood and blood components, plasma and plasma products (W.G. van Aken, H.W. Eijkhout). Intravenous fluids and infusions (P.I. Folb). Drugs affecting blood coagulation and fibrinolysis (J. Vermylen). Gastrointestinal drugs (J.M. Arnau, A. Vallano). Vitamins (H.D. Reuter). Corticotrophins and corticosteroids (S. Erill). Sex hormones and related compounds including oral contraceptives (A. Buitenhuis, C.J. van Boxtel). Thyroid hormones, iodine and antithyroid drugs (J.A. Franklyn). Insulin, glucagon and oral hypoglycemic drugs (H.M.J. Krans). Miscellaneous hormones and prostaglandins (J.R. Peters). Drugs affecting lipid metabolism (I. Aursnes). Cytostatics and immunosuppressive drugs (A. Stanley). Radiological contrast media (G. Ansell). Drugs used in ocular treatment (B.C. Polak). Drugs used in non-orthodox medicine (M.N.G. Dukes) Miscellaneous drugs, materials and medical devices (N.H. Choulis). International drug monitoring. Address list of national centres participating in the WHO drug monitoring scheme. Index of drugs. Index of side effects.
Under the supervision of the series editors, an international team of expert authors have gathered together the latest information on adverse drug effects from the international literature. In addition to describing new reports of adverse drug effects, the authors have subjected those reports to critical analysis, setting them into context in terms of clinical relevance and importance, and cross-referring to previous reports where necessary. New adverse effects are reported and evaluated and previously reported adverse effects are re-evaluated in the light of the most recent information. A special feature is the reviews, in which selected adverse effects are discussed in depth. The use of the book is enhanced by three separate indexes, allowing the reader to enter the text by drug name, adverse effect name, or drug interaction.
- © Elsevier Science 1995
- 1st August 1995
- Elsevier Science
- eBook ISBN:
Academic Medical Center, Amsterdam, The Netherlands
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
Department of Primary Health Care, University of Oxford, Oxford, UK